FDA Approves Gene Therapy

Share this story on:

Share on facebook
Share on twitter
Share on linkedin

WASHINGTON — Opening a new era in cancer care, U.S. health officials on Wednesday approved a breakthrough treatment that genetically engineers patients’ own blood cells into an army of assassins to seek and destroy childhood leukemia.

The Food and Drug Administration called the approval historic, the first gene therapy to hit the U.S. market. Made from scratch for every patient, it’s one of a wave of “living drugs” under development to fight additional blood cancers and other tumors, too.

Novartis Pharmaceuticals set the price for its one-time infusion of so-called “CAR-T cells” at $475,000, but said there would be no charge for patients who didn’t show a response within a month.

“This is a brand new way of treating cancer,” said Dr. Stephan Grupp of Children’s Hospital of Philadelphia, who treated the first child with CAR-T cell therapy — a girl who’d been near death but now is cancer-free for five years and counting. “That’s enormously exciting.”

CAR-T treatment uses gene therapy techniques not to fix disease-causing genes but to turbocharge T cells, immune system soldiers that cancer too often can evade. Researchers filter those cells from a patient’s blood, reprogram them to harbor a “chimeric antigen receptor” or CAR that zeroes in on cancer, and grow hundreds of millions of copies. Returned to the patient, the revved-up cells can continue multiplying to fight disease for months or years.

Teresa
Teresa

Recent Posts

Teresa

Humana Waives Some Copays

Humana is waiving member copays, co-insurance, and deductibles for in-network Primary Care, Behavioral Health, and Tele-Health visits for it’s Medicare Advantage customers.  This relief will

Read More »
Teresa

Humana Sues

“Humana filed suit Friday against more than a dozen generic drugmakers, including Teva Pharmaceutical, alleging the companies engage in price fixing. “In the 610-page complaint,

Read More »
Teresa

Canada Investigates

Health officials in London, Ontario, are investigating a case of vaping-related illness in a youth who suffered severe respiratory problems that have been linked to

Read More »
Teresa

Multi-Tasking or Focus?

“Given the importance of focus, it’s disheartening to find that like most of us, many of today’s business leaders and CEOs have fallen victim to

Read More »
Teresa

Indiana Leads

It was announced today that he and Mississippi Attorney General JimHood are leading a bipartisan coalition of 47 attorneys general callingupon Congress to authorize the

Read More »

copyright 2020 Evansville Insurance Center